Calprotectin (S100A8/A9) has been identified as a biomarker that can aid in predicting the severity of disease in COVID-19 patients. This study aims to evaluate the correlation between levels of circulating calprotectin (cCP) and the severity of COVID-19.
Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian study / Infantino, Maria; Manfredi, Mariangela; Alessio, Maria Grazia; Previtali, Giulia; Grossi, Valentina; Benucci, Maurizio; Faraone, Antonio; Fortini, Alberto; Grifoni, Elisa; Masotti, Luca; Russo, Edda; Amedei, Amedeo; FitzGerald, Emily; Albesa, Roger; Norman, Gary L; Mahler, Michael. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 1096-9071. - ELETTRONICO. - 94:(2022), pp. 5758-5765. [10.1002/jmv.28056]
Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian study
Faraone, Antonio;Fortini, Alberto;Grifoni, Elisa;Masotti, Luca;Russo, Edda;Amedei, Amedeo;
2022
Abstract
Calprotectin (S100A8/A9) has been identified as a biomarker that can aid in predicting the severity of disease in COVID-19 patients. This study aims to evaluate the correlation between levels of circulating calprotectin (cCP) and the severity of COVID-19.
| File | Dimensione | Formato | |
|---|---|---|---|
|
JMV-9999-0.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
1.41 MB
Formato
Adobe PDF
|
1.41 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
